Chronic inflammatory demyelinating polyneuropathy and diabetes

被引：0
作者：
Andrew J. M. Boulton
机构：
来源：
Current Diabetes Reports | 2003年 / 3卷 / 6期
关键词：
Diabetic Patient; Polyneuropathy; Intravenous Immunoglobulin; Chronic Inflammatory Demyelinating Polyneuropathy; Motor Neuropathy;
D O I：
10.1007/s11892-003-0004-2
中图分类号：
学科分类号：
摘要：
The authors concluded that an immunemediated demyelinating polyneuropathy is a well-recognized entity in diabetic patients, and for those with the clinical and EP features and significant functional deficits, immunomodulating therapy should be considered.
引用
收藏
页码：437 / 438
页数：1
相关论文
共 16 条
  • [1] Sharma KR(2002)Demyelinating neuropathy in diabetes mellitus Arch Neurol 59 758-765
  • [2] Cross J(2002)Diabetic demyelinating polyneuropathy responsive to intravenous immunoglobulin therapy Arch Neurol 59 751-757
  • [3] Farronay O(2002)Proposed revised electrophysiological criteria for chronic inflammatory demyelinating polyradiculoneuropathy Muscle Nerve 25 26-30
  • [4] Sharma KR(2000)The spectrum of chronic inflammatory demyelinating polyneuropathy J Neurol Sci 173 129-139
  • [5] Cross J(2002)Intravenous immunoglobulin as first treatment in diabetics with concomitant distal symmetric axonal polyneuropathy and CIDP J Neurol 249 719-722
  • [6] Ayyar DR(2002)Systematic reviews of treatment for inflammatory demyelinating neuropathy J Anat 200 331-339
  • [7] Nicolas G(undefined)undefined undefined undefined undefined-undefined
  • [8] Maisonobe T(undefined)undefined undefined undefined undefined-undefined
  • [9] Le Forestier N(undefined)undefined undefined undefined undefined-undefined
  • [10] Rotta FT(undefined)undefined undefined undefined undefined-undefined
12